Interferon alfa-2a (Roferon-A) monotherapy in chronic myelogenous leukemia: a pilot study in Nigerian patients in early chronic phase.

West African journal of medicine

Volumn 19, Issue 4, 2000, Pages 286-292

  Okanny, C C ^a   Durosimi, M A ^a   Chukwuani, C M ^a   Njoku, O S ^a   Akinola, N O ^a   Herrada, S C ^a   Ogbe, O P ^a   Onwukeme, K E ^a   Faluyi, J O ^a   Akanmu, A S ^a   Akinsete, I ^a  

^a LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BLOOD; BONE MARROW EXAMINATION; CHEMICALLY INDUCED DISORDER; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DRUG MONITORING; FEMALE; HUMAN; MALE; MIDDLE AGED; NIGERIA; PANCYTOPENIA; PATHOLOGY; PILOT STUDY; REMISSION; SAFETY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW EXAMINATION; CYTOGENETICS; DRUG MONITORING; FEMALE; HUMANS; INTERFERON ALFA-2A; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NIGERIA; PANCYTOPENIA; PILOT PROJECTS; REMISSION INDUCTION; SAFETY; TREATMENT OUTCOME;

EID: 0034303664     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)